A Rocking Good Time

The adoption of single-use bioreactor technology is expanding rapidly today because biopharmaceutical manufacturers now recognize the advantages that these systems provide. Advances in single-use bioreactor technology in response to the changing regulatory environment, the introduction of new cull culture systems and processes, and the desire of the industry to leverage process analytical technology are also contributing to the growing application of single-use bioreactors.

Even established bioreactor technologies are being upgrades to meet current needs. One such system is the ReadyToProcess WAVE 25 single-use bioreactor system from GE Healthcare Life Sciences. The new system incorporates all of the key features of the original WAVE bioreactors – and particularly the use of a rocking motion rather than stirring – plus extensive additional functionality, but it is even easier to use than the original system, according to the company.

What are you looking for in single-use bioreactors today? Do the bioreactors that are available meet your needs? Why types of functionality do you want to see – easier bag handling, automated feedback loops for increased automatic control of reaction conditions, the ability to create your own methods, a more friendly user-interface and expanded data management systems, something else?

If you haven’t already, be sure to sign up for the eNewsletter so that you can read what experts in the field have to say. Then let us know what you think. Also check out the Pharmaceutical Technology/Biopharm International Marketplace at www.pharmabiomarketplace.com.

Cynthia Challener, PhD

Editor

The Pharmaceutical Sciences, Manufacturing & Marketplace Report